Tim Kanters

Tim Kanters is a Research Fellow at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam, specializing in Health Technology Assessment (HTA). He holds a Master’s in Economics & Geography (2007) and Health Economics (2008) from Utrecht and Erasmus University Rotterdam, respectively. His work focuses on cost-effectiveness analyses of therapies for orphan diseases, notably enzyme replacement therapy for Pompe disease, and broader applications in epilepsy, geriatric care, and digital health technologies.

• Research Trends: His studies span Health Technology Assessment, Cost-Effectiveness Analysis, and Quality of Life in rare diseases and long-term care.

Kanters contributes to the Dutch Costing Manual and collaborates on international projects like the EPISODE Study, addressing healthcare resource allocation and caregiver burden. His datasets on Pompe disease and cryopyrin-associated periodic syndrome highlight his impact in rare disease economics.